High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID‐19 patients: HMGB1 as a biomarker of worst prognosis

• Main Authors: Amanda Roberta Revoredo Vicentino (Author), Vanderlei da Silva Fraga‐Junior (Author), Matheus Palazzo (Author), Natalia Recardo Amorim Tasmo (Author), Danielle A. S. Rodrigues (Author), Shana Priscila Coutinho Barroso (Author), Sâmila Natiane Ferreira (Author), Anna Cristina Neves‐Borges (Author), Diego Allonso (Author), Marcelo Rosado Fantappié (Author), Julio Scharfstein (Author), Ana Carolina Oliveira (Author), Rosane Vianna‐Jorge (Author), André Macedo Vale (Author), Robson Coutinho‐Silva (Author), Luiz Eduardo Baggio Savio (Author), Claudio Canetti (Author), Claudia Farias Benjamim (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The severe acute respiratory syndrome coronavirus 2, the agent of the ongoing coronavirus disease 2019 (COVID‐19) pandemic, has spread worldwide since it was first identified in November 2019 in Wuhan, China. Since then, progress in pathogenesis linked severity of this systemic disease to t...